TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: neonatal respiratory distress requiring intensive care
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mean improvement in self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: self-rated confidence scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self-rated ability to work independently on weekends
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: 6-month pedometer steps per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: laparoscopic suturing ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: D2 performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hit rate on the secondary task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pro-inflammatory cytokines levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mucosal immune mediators levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Running-induced acid reflux duration and frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in lymphokine-secreting cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Intraclass Correlation Coefficient (ICC) comparing modes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to complete the questionnaire
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of participants reporting 'no problems'
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Gingival scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Improvement in tinnitus symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence rate of DVT
Endpoint domain: Adverse events/effects
Primary endpoint: Umbilical artery pH values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived need for a physiotherapist
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Enjoyment of core techniques
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of life at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Body mass index z-score (BMIz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decrease in the mean number of cigarettes smoked per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-day smoking abstinence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attempts to quit smoking in occasional smokers
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Yield of direct screening versus stepped screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Riboflavin status improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of tadalafil
Endpoint domain: Adverse events/effects
Primary endpoint: Intensity of postoperative pain at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Operating time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean operating costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Lightening of black tattoos
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean daily intake of riboflavin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dietary Reference Intakes for thiamin and iron
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dietary Reference Intakes for calcium and copper
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: decline in function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: impaired growth and development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: impaired HRQL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: low-contrast visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angina rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Duke Activity Status Index scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Death/myocardial infarction/cerebrovascular accident
Endpoint domain: Mortality/survival
Primary endpoint: Rate of failed intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mortality risk associated with frequent VPBs
Endpoint domain: Mortality/survival
Primary endpoint: Aortic pressure-diameter relation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PWAT improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WSA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular morbidity risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Atelectasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of preterm birth
Endpoint domain: Mortality/survival
Primary endpoint: Deterrent effect of jail penalty on DUI decisions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean differences in IOP measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in serum HDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bone mineral density T-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deterioration in neonatal skills and knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for intubation and mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: partner caregiver burden
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Muscle thickness of the anterior aspect of the thigh
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximal isokinetic knee extension strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: V˙O2 peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dietary variety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: emotional functioning concern
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: sexual functioning concern
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: financial concern
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: amelioration of fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: inhibition of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: reduction of fibrosis markers (HA, TGF-β, MMP-2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: correct compressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery after surgery
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: CRQ scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CAT score change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time taken to complete movement exercises
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken to complete cutting exercises
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken to complete suture/knot exercises
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aerobic gram‐negative bacilli (AGNB) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: D‐lactate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sperm progressive motility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DNA fragmentation index (DFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of eradication of H pylori infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inter- and intra-rater reproducibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Submucosal dissection time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NASA Task Load Index score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: treatment success at 5 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cure proportions at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual AHI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mortality during induction
Endpoint domain: Mortality/survival
Primary endpoint: Nephrotoxicity rates
Endpoint domain: Adverse events/effects
Primary endpoint: Mean cardiac output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Treatment decisions per 48 hours
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Emergency care visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Low-Density Lipoprotein Cholesterol (LDL-c) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of subjects with fasting TC ≥200 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Brachial Systolic Blood Pressure (BSBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Aortic Systolic Blood Pressure (ASBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Augmentation Index (AIx)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Post-prandial NEFA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: GH peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: graft resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of newly diagnosed AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oxygen therapy compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-care ability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cases of cataract
Endpoint domain: Physiological/clinical
Endpoint subdomain: Eye outcomes
Primary endpoint: AGER1 and SIRT1 mRNA and protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AKSS scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: serum CRP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in daily hours of crying
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in maternal anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intraoperative bleeding volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cognitive improvement in word-list recognition and recall test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life-Alzheimer's Disease of caregivers
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 3-month BSCVA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence in diagnosing CFS/ME
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Grade 3+ gastrointestinal toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 3+ genitourinary toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: PCT change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ProADM change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRP change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge about elevated glucose levels
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: intention to undergo metabolic testing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Markers of bone formation and resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PDL cell adhesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Linkage to HIV care
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: observer-rated severity of depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depressive and anxiety symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular mortality plus HF hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CPITN (Community Periodontal Index of Treatment Needs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily drug doses
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: recurrence of LUTI
Endpoint domain: Mortality/survival
Primary endpoint: weighted mean pulse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oral glucose‐induced insulin secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Colonic transit improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Success rates of immediate reconstruction with titanium plate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete response (no nausea, no retching, no vomiting)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sick leave
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: cure and improvement rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse event frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in shade values (lightness and chroma)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of plate removal
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in serum potassium level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: composite primary efficacy end point (stroke, systemic embolism, cardiovascular death)
Endpoint domain: Mortality/survival
Primary endpoint: Progression of diastolic dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in psoriasis area and severity index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in self‐administered psoriasis area and severity index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time to no pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of escape medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Norepinephrine level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low-frequency power in normalized units
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathological complete response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: EPDS score of ≥10
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: EPDS score of ≥13
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Vasodilator responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cure or improvement of cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive outcome after anal surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of anal disease requiring further surgery
Endpoint domain: Adverse events/effects
Primary endpoint: mean symptom frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset of appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glucose-lowering effect (AUCGIR,0-30 min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rates of high platelet reactivity (HPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: EET improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: trough FEV1 improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pertussis infection development
Endpoint domain: Mortality/survival
Primary endpoint: Suppression of auditory transient evoked 40-Hz responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of participants who were gadolinium-enhancing lesion-free
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unadjusted annualized relapse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marginal gap
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Internal adaptation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median carotid stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: long-term compliance with therapy
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Patient Global Assessment (PtGA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF-36 Physical Component Summary Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Hospitalization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy for predicting complicated fUTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of distance driven above the speed limit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal increment of LH after injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Maximal increment of FSH after injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: SF-6D index scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean improvement in FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Asthma exacerbation rates
Endpoint domain: Adverse events/effects
Primary endpoint: mMASI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Individual Typological Angle parameters increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of correct knowledge responses
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: number of correct behaviour responses
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Minimum Important Difference (MID) for Ambulatory Capacity Distance (ACD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum Important Difference (MID) for Functional Capacity Distance (FCD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in medical outcome
Endpoint domain: Mortality/survival
Primary endpoint: Rate of disease control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade ≥3 treatment emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Need for time off
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Counseling availability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Formal strategy for assistance
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Serum Hs-CRP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean levels of AOPP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes